|
|
Article: Pay Attention to Cholesterol-Lowering Statin Intake Guidelines -- Not Brand Names -- Harvard Heart Letter Advises.
- Article from:
- PR Newswire
- Article date:
- November 24, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BOSTON, Nov. 24 /PRNewswire/ -- The market for cholesterol-lowering drugs is a multibillion dollar business. With the arrival of new statins, patients are faced with the question of which brand is the best. The December issue of Harvard Heart Letter dissects the myriad of choices and equips readers with sound ways to maximize the benefits of statins, regardless of brand.
Although the six leading statins on the market target the same step in the cholesterol-making process, there are differences between them. To help readers distinguish among the selection, the December issue of Harvard Heart Letter examines these leading statins based on potency, proof of ...